Factors associated with referral to outpatient cardiac rehabilitation services

Natalie Johnson1, Janet Fisher, Amanda Nagle

  • 1Centre for Clinical Epidemiology and Biostatistics, School of Medical Practice and Population Health, The University of Newcastle, NSW, Australia. Natalie.Johnson@newcastle.edu.au

Insights

Referral to cardiac rehabilitation is low despite guidelines. Younger patients, those with prior participation, and specific diagnoses like acute myocardial infarction or coronary artery bypass surgery were more likely to be referred.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Cardiac rehabilitation is recommended for all cardiovascular disease patients.
  • Participation rates in cardiac rehabilitation remain low in Western countries.
  • Identifying referral barriers is crucial for improving access.

Purpose of the Study:

  • To investigate factors associated with outpatient cardiac rehabilitation referral.
  • Study focused on the Hunter region of New South Wales, Australia.
  • Aim was to understand referral patterns in a specific Australian population.

Main Methods:

  • Analysis of 1933 eligible patients discharged from public hospitals.
  • Data collected from the Hunter Area Heart and Stroke Register and patient questionnaires.
  • Logistic regression used to identify independent predictors of referral.

Main Results:

  • 41% of eligible patients were referred to outpatient cardiac rehabilitation.
  • Younger age (<65 years) was associated with higher referral rates.
  • Referral was linked to previous cardiac rehabilitation, hospital provision, acute myocardial infarction, and coronary artery bypass surgery.

Conclusions:

  • Specific patient and hospital factors predict referral to cardiac rehabilitation.
  • Younger patients, those with prior experience, and post-MI/CABG patients were more likely referred.
  • Strategies to increase referral rates, possibly using quality management, are needed.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...